Tag: Evercore ISI
-
Gilead Pullback a Potential Overreaction
Gilead (GILD) fell about 10%, or $8.86 on a disappointing cancer drug study. According to NBC, “The company did not significantly extend the lives of patients with certain lung cancer in a late-stage trial. The phase-three study was part of an effort to expand the use of Trodelvy, which is already approved to treat some…
-
Apple (AAPL) Could be a Big Winner in 2023
Markets have been all over the place these last few days of the year. However, we are seeing opportunities. Look at Apple, for example. After dropping from about $150, the tech stock caught strong double-bottom support dating back to mid-June. RSI, MACD, and Williams’ %R are also oversold at the moment. From a current price…
-
What Just Happened to Netflix?
If you’re thinking of buying Netflix (NFLX), don’t. Unfortunately for NFLX, the pain may last awhile. Not only did the company just report its first subscriber loss in about 10 years, analysts are out with reduced price targets. Wedbush just lowered its price target from $342 to $280. Evercore ISI just lowered its from $525…
-
It’s Not Time to Buy the Shopify Fear Just Yet
Keep an eye on Shopify (SHOP). At the moment, the stock is getting crushed after Goldman Sachs’ analyst Gabriela Borges initiated coverage of the stock with a neutral rating. While “she says the company is well-positioned long term, but she sees near-term headwinds. For one thing, Borges says that a recent slowing of gross-merchandise-value growth…